[-] Show simple item record

dc.contributor.authorNeher, Jon O.eng
dc.contributor.authorSafranek, Saraheng
dc.date.issued2003eng
dc.description.abstractThree beta-blockers--carvedilol, metoprolol, and bisoprolol--reduce mortality in chronic heart failure caused by left ventricular systolic dysfunction, when used in addition to diuretics and angiotensin converting enzyme (ACE) inhibitors (strength of recommendation [SOR]: A, based on large randomized placebo-controlled trials). No differences in mortality or patient tolerance have been demonstrated in studies comparing carvedilol and metoprolol (SOR: B, based on small head-to-head trials).eng
dc.identifier.urihttp://hdl.handle.net/10355/2976eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2003 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 52, no. 05 (May 2003): 396+.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectpatient toleranceeng
dc.subjectmortalityeng
dc.subjectangiotensin converting enzyme (ACE) inhibitorseng
dc.subjectsystolic dysfunctioneng
dc.subject.lcshAngiotensin converting enzyme -- Inhibitors -- Therapeutic useeng
dc.subject.lcshCongestive heart failure -- Treatmenteng
dc.subject.lcshAdrenergic beta blockerseng
dc.titleWhat is the most effective beta-blocker for heart failure?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record